Autologous conditioned serum (Orthokine) injection for treatment of classical trigeminal neuralgia: results of a single‑center case series

Autologous conditioned serum (Orthokine) injection for treatment of classical trigeminal neuralgia: results of a single‑center case series


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: داود آقا محمدی , سید کاظم شکوری بیلانکوهی , یاشار اسلامپور , ندا دولت خواه

کلمات کلیدی: Autologous conditioned serum, Trigeminal neuralgia, Numeric rating scale

نشریه: 20750 , 183 , 16 , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله ندا دولت خواه
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه طب فیزیکی وتوانبخشی
کد مقاله 78634
عنوان فارسی مقاله Autologous conditioned serum (Orthokine) injection for treatment of classical trigeminal neuralgia: results of a single‑center case series
عنوان لاتین مقاله Autologous conditioned serum (Orthokine) injection for treatment of classical trigeminal neuralgia: results of a single‑center case series
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Case Report
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: Despite some advances, treatment of trigeminal neuralgia remains a signifcant challenge. This study determines the efcacy and safety of autologous conditioned serum (Orthokine) injection into the foramen oval to treat refractory trigeminal neuralgia. Case presentation: This is a consecutive case series from the Pain and Palliative Care Department of Imam Reza University Hospital, Tabriz, Iran. Eleven Iranian patients, eligible according to the inclusion and exclusion criteria, aged 45.64 ±11.58 years (Four male and seven female, all Iranian) with established classical trigeminal neuralgia were injected with Orthokine (2 mL per injection) once a week for three consecutive weeks (total of four injections). Numeric rating scale scores for facial pain intensity and also carbamazepine daily dose were confrmed at pretreatment (T0) and at week 1 (T1), week 2 (T2), week 3 (T3), week 4 (T4), and month 2 (T5) posttreatment. Pain intensity was signifcantly reduced in the frst 3 weeks of follow-up in comparison with baseline (T0 to T3) (8.18 ± 1.99 to 2.82 ± 2.13, p < 0.001), an efect that was retained at week 4 (T4) and month 2 (T5) follow-ups (2.82 ± 2.13 to 3.36 ± 2.69, p = 0.886). Carbamazepine consumption was signifcantly reduced in the frst 3 weeks of follow-up in comparison with baseline (T0 to T3) (636.36 ± 307.48 to 200.00 ± 296.64, p = 0.003), an efect that was retained at week 4 and month 2 follow-ups (200.00 ± 296.64 to 200.00 ± 282.84, p = 0.802). There were no serious adverse events in participants. Conclusion: Orthokine injection led to consistent pain relief and reduced carbamazepine dosage in patients with trigeminal neuralgia, with acceptable safety.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
داود آقا محمدیاول
سید کاظم شکوری بیلانکوهیسوم
یاشار اسلامپورچهارم
ندا دولت خواهپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Aghamohammadi_et_al-2022-Journal_of_Medical_Case_Reports.pdf1401/02/181274744دانلود